Journals / Türk Nefroloji Diyaliz ve Transplantasyon Dergisi / 2017 / Cilt: 26 - Sayı: 2

Hemodiyaliz Hastalarında Nötrofil Lenfosit Oranı Aterosklerozu mu Gösteriyor?

Does Neutrophil to Lymphocyte Ratio Tell Something About Atherosclerosis in Hemodialysis Patients?

Pages
166–170
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

By regression analysis age (?=.527, p=0.00), CRP (?=.419, p=0.001) and NLR (?=.251, p=0.022) were found to be independent determinants of CIMT.CONCLUSION: NLR was found to be independently correlated with CIMT in haemodialysis patients and may be used in cardiovascular risk assessment in clinical practice.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: Atherosclerotic cardiovascular disease (CVD) is an important cause of mortality and morbidity in end-stage renal disease (ESRD).
📊
Key Findings & Data:The aim of this study was to detect the relationship between NLR, C-reactive protein and CIMT.MATERIAL and METHODS: 75 hemodialysis patients (42 female, 33 male) were included in this study.
💡
Conclusion & Impact:By regression analysis age (?=.527, p=0.00), CRP (?=.419, p=0.001) and NLR (?=.251, p=0.022) were found to be independent determinants of CIMT.CONCLUSION: NLR was found to be independently correlated with CIMT in haemodialysis patients and may be used in cardiovascular risk assessment in clinical practice.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: Atherosclerotic cardiovascular disease (CVD) is an important cause of mortality and morbidity in end-stage renal disease (ESRD). Atherosclerotic changes in carotid arteries show the extent of systemic atherosclerosis. Carotid intima media thickness (CIMT) can be measured by ultrasonography. Inflammation is included in pathogenesis of atherosclerosis. Neutrophil to lymphocyte ratio (NLR) may show inflammation and the patients who has higher cardiovascular risk. The aim of this study was to detect the relationship between NLR, C-reactive protein and CIMT.MATERIAL and METHODS: 75 hemodialysis patients (42 female, 33 male) were included in this study. Patients with active infection, known malignancy and a cardiovascular disease were excluded. CIMT was measured by B mode ultrasonography. Patients' laboratory parameters at the time of inclusion were noted and NLR was calculated. RESULTS: Mean age was 58.07±16.23 years and 44% of the patients were male. Mean dialysis vintage was 79.27±67.06 months. In correlation analysis, CIMT was positively correlated with age, CRP and NLR (respectively r=.380 p=.001; r=.255 p=.005; r=.283 p=.014). By regression analysis age (?=.527, p=0.00), CRP (?=.419, p=0.001) and NLR (?=.251, p=0.022) were found to be independent determinants of CIMT.CONCLUSION: NLR was found to be independently correlated with CIMT in haemodialysis patients and may be used in cardiovascular risk assessment in clinical practice.

Özet

AMAÇ: Son dönem böbrek yetmezliğinde (SDBY) kardiyovasküler hastalık mortalite ve morbiditenin en önemli nedenidir. Aterosklerozun göstergesi olan karotis intima medya kalınlığında (KİMK) artış SDBY de kardiyovasküler hastalığın bir belirtecidir. İnflamasyon aterosklerozun patogenezinde rol oynamaktadır. Beyaz küre sayısının kardiyovasküler olaylar için bağımsız bir belirteç olduğu bildirilmektedir. Nötofil- lenfosit oranı (NLO) kardiyovasküler olaylar açısından risk altında olan hastaları gösterebilir. SDBY nedeniyle hemodiyalize giren hastalarda ateroskleroz belirteci olan KİMK ile NLO ve CRP arasında ilişki olup olmadığını araştırmayı hedefledik. GEREÇ ve yÖNTEMLER: Bu kesitsel çalışmaya hastanemiz hemodiyaliz ünitesinde en az 6 aydır hemodiyalize giren, bilinen aktif enfeksiyonu, kardiyovasküler hastalığı, malignitesi olmayan 75 hasta (42 kadın, 33 erkek) dahil edildi. Hastaların KİMK'ları B mod ultrasonografi kullanılarak ölçüldü. Hastaların çalışmaya dahil edildikleri andaki laboratuvar parametreleri kaydedilerek nötrofil lenfosit oranları hesaplandı. BULGULAR: Ortalama yaş 58.07±16.23 yıl idi ve hastaların %44 ü erkek idi. Ortalama diyaliz süresi 79,27±67,06 ay idi. Yapılan korelasyon analizinde KİMK nın yaş, CRP ve NLO ile pozitif korele olduğu tespit edildi (sırasıyla r=,380 p=,001 ; r=,255 p=,005; r=,283 p=,014). Yapılan regresyon analizinde yaş (?=,527, p=0,00), CRP (?=,419, p=0,001) ve NLO (?=,251, p=0,022) nun KİMK nın bağımsız belirleyicileri olduğu tespit edildi.SONUÇ: SDBY nedeniyle hemodiyalize giren hastalarda yüksek NLO bağımsız olarak KİMK ile ilişkilidir ve klinik pratikte kardiyovasküler risk değerlendirilmesinde kullanılabilir.

🔖

Cite This Article

ESER, B., CANBAKAN, B., AYLI, M. D., YAYAR, Ö., YAYAR, O., BÜYÜKBAKKAL, M., MERHAMETSİZ, Ö., GÖK, E. O. (2022). Hemodiyaliz Hastalarında Nötrofil Lenfosit Oranı Aterosklerozu mu Gösteriyor?. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, Cilt: 26 - Sayı: 2, 166–170. https://ajindex.com/articles/655020

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Johnston N, Dargie H, Jardine A: Diagnosis and treatment of coronary artery disease in patients with chronic kidney disease: Ischemic heart disease. Heart 2008;94:1080-1088
  2. Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, Tranaeus A, Stenvinkel P, Lindholm B: Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 2008;3:1526-1533
  3. Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, Teehan BP, Levey AS: Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000;58:353-362
  4. Ortiz A, Massy ZA, Fliser D, Lindholm B, Wiecek A, Martínez- Castelao A, Covic A, Goldsmith D, Süleymanlar G, London GM, Zoccali C: Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis. Nat Rev Nephrol 2011;8:141-150
  5. Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR, Renlund DG, Muhlestein JB; Intermountain Heart Collaborative Study Group: Which white blood cell subtypes predict increased cardiovascular risk? J AmColl Cardiol 2005;45:1638-1643
  6. Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ: The systemic inflammation-based neutrophillymphocyte ratio: Experience in patients with cancer. Crit Rev Oncol Hematol 2013;88:218-230
  7. Arbel Y, Finkelstein A, Halkin A, Birati EY, Revivo M, Zuzut M, Shevach A, Berliner S, Herz I, Keren G, Banai S: Neutrophil/ lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. Atherosclerosis 2012;225:456-460
  8. Shah N, Parikh V, Patel N, Patel N, Badheka A, Deshmukh A, Rathod A, Lafferty J: Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction of coronary heart disease mortality: Insights from the National Health and Nutrition Examination Survey-III. Int J Cardiol 2014;171:390-397
  9. Gary T, Pichler M, Belaj K, Hafner F, Gerger A, Froehlich H, Eller P, Pilger E, Brodmann M: Neutrophil-to-lymphocyte ratio and its association with critical limb ischemia in PAOD patients. PLoS One 2013;8:e56745 Kocyigit I, Eroglu E, Unal A, Sipahioglu MH, Tokgoz B, Oymak O, Utas C: Role of neutrophil/lymphocyte ratio in prediction of disease progression in patients with stage-4 chronic kidney disease. J Nephrol 2013;26:358-365
  10. Solak Y, Yilmaz MI, Sonmez A, Saglam M, Cakir E, Unal HU, Gok M, Caglar K, Oguz Y, Yenicesu M, Karaman M, Ay SA, Gaipov A, Turk S, Vural A, Carrero JJ: Neutrophil to lymphocyte ratio independently predicts cardiovas